Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169.
N Engl J Med. 2023.
PMID: 38055253
Clinical Trial.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators.
Westin SN, et al. Among authors: thomes pepin j.
J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21.
J Clin Oncol. 2024.
PMID: 37864337
Free PMC article.
Clinical Trial.
Item in Clipboard
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Pignata S, Bookman M, Sehouli J, Miller A, Penson RT, Taskiran C, Anderson C, Hietanen S, Myers T, Madry R, Willmott L, Lortholary A, Thomes-Pepin J, Aghajanian C, McCourt C, Stuckey A, Wu X, Nishio S, Copeland LJ, He Y, Molinero L, Patel S, Lin YG, Khor VK, Moore KN.
Pignata S, et al. Among authors: thomes pepin j.
Gynecol Oncol. 2023 Oct;177:20-31. doi: 10.1016/j.ygyno.2023.06.018. Epub 2023 Aug 23.
Gynecol Oncol. 2023.
PMID: 37625235
Clinical Trial.
Item in Clipboard
Challenges of conversion from robotic surgery for vascular complications.
Lau PJ, McGreevy JM, Thomes Pepin JA, Ramaswamy A, Faizer R.
Lau PJ, et al. Among authors: thomes pepin ja.
J Vasc Surg Cases Innov Tech. 2022 Sep 29;9(2):101035. doi: 10.1016/j.jvscit.2022.09.010. eCollection 2023 Jun.
J Vasc Surg Cases Innov Tech. 2022.
PMID: 37013065
Free PMC article.
Item in Clipboard
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Moore KN, Bookman M, Sehouli J, Miller A, Anderson C, Scambia G, Myers T, Taskiran C, Robison K, Mäenpää J, Willmott L, Colombo N, Thomes-Pepin J, Liontos M, Gold MA, Garcia Y, Sharma SK, Darus CJ, Aghajanian C, Okamoto A, Wu X, Safin R, Wu F, Molinero L, Maiya V, Khor VK, Lin YG, Pignata S.
Moore KN, et al. Among authors: thomes pepin j.
J Clin Oncol. 2021 Jun 10;39(17):1842-1855. doi: 10.1200/JCO.21.00306. Epub 2021 Apr 23.
J Clin Oncol. 2021.
PMID: 33891472
Free PMC article.
Clinical Trial.
Item in Clipboard
Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer.
Cardenas H, Jiang G, Thomes Pepin J, Parker JB, Condello S, Nephew KP, Nakshatri H, Chakravarti D, Liu Y, Matei D.
Cardenas H, et al. Among authors: thomes pepin j.
NPJ Precis Oncol. 2019 Dec 6;3:32. doi: 10.1038/s41698-019-0103-4. eCollection 2019.
NPJ Precis Oncol. 2019.
PMID: 31840082
Free PMC article.
Item in Clipboard
Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.
Li J, Condello S, Thomes-Pepin J, Ma X, Xia Y, Hurley TD, Matei D, Cheng JX.
Li J, et al. Among authors: thomes pepin j.
Cell Stem Cell. 2017 Mar 2;20(3):303-314.e5. doi: 10.1016/j.stem.2016.11.004. Epub 2016 Dec 29.
Cell Stem Cell. 2017.
PMID: 28041894
Free PMC article.
Item in Clipboard
Cite
Cite